SONOMA VALLEY HEALTH CARE DISTRICT
1. Target Overview & Investment Thesis
SONOMA VALLEY HEALTH CARE DISTRICT is a 24-bed rural/critical access in SONOMA, CA with $55.0M in net patient revenue and a -16.5% operating margin. The hospital serves a payer mix of 44.7% Medicare, 2.0% Medicaid, and 53.3% commercial.
Thesis: Turnaround. Our ML models identify $4.0M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -16.5% to -9.1% (+736bps).
| Net Revenue HCRIS | $55.0M |
| Current EBITDA COMPUTED | $-9.1M |
| Operating Margin COMPUTED | -16.5% |
| Occupancy HCRIS | 36.8% |
| Revenue / Bed COMPUTED | $2.3M |
| Net-to-Gross HCRIS | 17.0% |
| Distress Probability ML | 48.1% |
2. Market Context & Competitive Position
CA has 414 Medicare-certified hospitals with a median operating margin of -4.9%. The target's margin of -16.5% places it below the state median. Among 63 size-comparable peers (12-48 beds), the median margin is -9.3%. The target's below-peer margin suggests operational improvement opportunity.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (12-48), prioritizing same-state peers. 63 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| SONOMA VALLEY HEALTH CARE DIST (Target) | CA | 24 | $55.0M | -16.5% |
| TAHOE FOREST HOSPITAL | CA | 25 | $264.3M | 13.0% |
| PORTERVILLE DEVELOPMENTAL CENT | CA | 17 | $193.6M | -6.0% |
| SUTTER DAVIS HOSPITAL | CA | 48 | $176.9M | 12.5% |
| ADVENTIST HEALTH CLEARLAKE | CA | 25 | $159.9M | -6.3% |
| RIDGECREST REGIONAL HOSPITAL | CA | 25 | $149.6M | -14.7% |
| HAZEL HAWKINS MEM. HOSPITAL | CA | 25 | $141.1M | -16.7% |
| GOLETA VALLEY COTTAGE HOSPITAL | CA | 24 | $111.9M | 14.8% |
| FAIRCHILD MEDICAL CENTER | CA | 25 | $109.4M | -0.3% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $4.0M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $1.2M | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $1.1M | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $1.1M | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $669K | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $35K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $-9.1M |
| + RCM Uplift | +$4.0M |
| Pro Forma EBITDA | $-5.0M |
| Current Margin | -16.5% |
| Pro Forma Margin | -9.1% |
| WC Released (1x) | $2.1M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $-14.0M | $-19.3M | 0.00x | -100.0% |
| Base (11x exit) | 10.0x | 11.0x | $-14.0M | $-25.8M | 0.00x | -100.0% |
| Bull Case | 9.0x | 11.0x | $-12.6M | $-16.9M | 0.00x | -100.0% |
| Bull (12x exit) | 9.0x | 12.0x | $-12.6M | $-22.2M | 0.00x | -100.0% |
| Bear Case | 11.0x | 10.0x | $-15.3M | $-35.0M | 0.00x | -100.0% |
| Bear (11x exit) | 11.0x | 11.0x | $-15.3M | $-43.5M | 0.00x | -100.0% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| High | Negative operating margin | RCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion |
| Low | Low net-to-gross ratio | Large contractual allowances suggest pricing discipline issues. Mitigant: payer renegotiation is an additional upside lever |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 63 hospitals with 12-48 beds
- Same-state prioritization (n=64)
- Comp margins: P25=-19.6% / P50=-9.3% / P75=0.9%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.